Mirae Asset Global Investments Co., Ltd. Gilead Sciences, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$54.3 Billion
Q1 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,471,302 shares of GILD stock, worth $98 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,471,302

Previous 1,439,735 2.19%

Holding current value

$98 Million

Previous $117 Million 7.6%

% of portfolio

0.2%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$71.58 - $87.29 $2.26 Million - $2.76 Million	31,567 Added 2.19%	1,471,302 $108 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $7.4 Million - $8.4 Million	-101,041 Reduced 6.56%	1,439,735 $117 Million
Q3 2023 Oct 26, 2023	BUY	$73.94 - $80.67 $12.2 Million - $13.3 Million	164,822 Added 11.98%	1,540,776 $115 Million
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $2.77 Million - $3.16 Million	-36,436 Reduced 2.58%	1,375,954 $106 Million
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $15.7 Million - $17.8 Million	-202,502 Reduced 12.54%	1,412,390 $117 Million

Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $1.58 Million - $2.27 Million	-25,399 Reduced 1.55%	1,614,892 $139 Million
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $1.29 Million - $1.48 Million	-21,718 Reduced 1.31%	1,640,291 $101 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $14 Million - $15.7 Million	242,204 Added 17.06%	1,662,009 $103 Million
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $1.44 Million - $1.62 Million	-24,897 Reduced 1.72%	1,419,805 $87.8 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $15.2 Million - $19.1 Million	263,212 Added 22.28%	1,444,702 $85.9 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $12.1 Million - $13.7 Million	186,429 Added 18.74%	1,181,490 $85.8 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $11.3 Million - $12.2 Million	166,873 Added 20.15%	995,061 $69.5 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $7.54 Million - $8.24 Million	118,874 Added 16.76%	828,188 $57 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $6.07 Million - $6.92 Million	101,148 Added 16.63%	709,314 $45.8 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $6.75 Million - $7.69 Million	119,143 Added 24.36%	608,166 $35.4 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $3.47 Million - $4.37 Million	55,940 Added 12.92%	489,023 $30.9 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $5.59 Million - $6.49 Million	77,269 Added 21.72%	433,083 $33.3 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $2.08 Million - $2.66 Million	33,197 Added 10.29%	355,814 $26.6 Million
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $354,561 - $390,006	5,754 Added 1.82%	322,617 $21 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.52 Million - $2.78 Million	40,326 Added 14.58%	316,863 $20.1 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $1.48 Million - $1.66 Million	23,997 Added 9.5%	276,537 $18.7 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $1.96 Million - $2.19 Million	31,302 Added 14.15%	252,540 $16.3 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $899,927 - $1.17 Million	14,865 Added 7.2%	221,238 $13.8 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $3.97 Million - $4.4 Million	55,732 Added 37.0%	206,373 $15.9 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $1.19 Million - $1.39 Million	18,416 Added 13.93%	150,641 $10.6 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $867,670 - $1.06 Million	11,912 Added 9.9%	132,225 $9.97 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $77,055 - $90,452	1,083 Added 0.91%	120,313 $8.62 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $2.04 Million - $2.42 Million	28,339 Added 31.18%	119,230 $9.66 Million
Q2 2017 Aug 14, 2017	BUY	N/A	90,891	90,891 $6.43 Million

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.5B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Gilead Sciences, Inc. Transaction History